快速访问
文章信息
参考文献
[1]COLLABORATORS G B D A R. Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050 [J]. Lancet (London, England), 2024, 404(10459): 1199-226.
[2]POWER E. Impact of antibiotic restrictions: the pharmaceutical perspective [J]. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2006, 12 Suppl 5: 25-34.
[3]ASLAM B, WANG W, ARSHAD M I, et al. Antibiotic resistance: a rundown of a global crisis [J]. Infection and drug resistance, 2018, 11: 1645-58.
[4]BENNETT A F, LENSKI R E. An experimental test of evolutionary trade-offs during temperature adaptation [J]. Proc Natl Acad Sci U S A, 2007, 104 Suppl 1(Suppl 1): 8649-54.
[5]MICHAUX C, RONNEAU S, GIORGIO R T, et al. Antibiotic tolerance and persistence have distinct fitness trade-offs [J]. PLoS pathogens, 2022, 18(11): e1010963.
[6]MAHMUD H A, SEO H, KIM S, et al. Synthesis and activity of BNF15 against drug-resistant Mycobacterium tuberculosis [J]. Future medicinal chemistry, 2021, 13(3): 251-67.
[7]SINCLAIR D, GOGTAY N, BRAND F, et al. Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria [J]. The Cochrane database of systematic reviews, 2011, (7): Cd008492.
[8]BREPOELS P, APPERMANS K, PéREZ-ROMERO C A, et al. Antibiotic Cycling Affects Resistance Evolution Independently of Collateral Sensitivity [J]. Molecular biology and evolution, 2022, 39(12).
[9]PáL C, PAPP B, LáZáR V. Collateral sensitivity of antibiotic-resistant microbes [J]. Trends in microbiology, 2015, 23(7): 401-7.
[10]AULIN L B S, LIAKOPOULOS A, VAN DER GRAAF P H, et al. Design principles of collateral sensitivity-based dosing strategies [J]. Nature communications, 2021, 12(1): 5691.
[11]BARBOSA C, RöMHILD R, ROSENSTIEL P, et al. Evolutionary stability of collateral sensitivity to antibiotics in the model pathogen Pseudomonas aeruginosa [J]. eLife, 2019, 8.
[12]SøRUM V, ØYNES E L, MøLLER A S, et al. Evolutionary Instability of Collateral Susceptibility Networks in Ciprofloxacin-Resistant Clinical Escherichia coli Strains [J]. mBio, 2022, 13(4): e0044122.
[13]NICHOL D, RUTTER J, BRYANT C, et al. Antibiotic collateral sensitivity is contingent on the repeatability of evolution [J]. Nature communications, 2019, 10(1): 334.
[14]PARTRIDGE S R, KWONG S M, FIRTH N, et al. Mobile Genetic Elements Associated with Antimicrobial Resistance [J]. Clinical microbiology reviews, 2018, 31(4).
[15]WANG Q, WEI S, SILVA A F, et al. Cooperative antibiotic resistance facilitates horizontal gene transfer [J]. The ISME journal, 2023, 17(6): 846-54.
[16]ALLEN R C, PFRUNDER-CARDOZO K R, HALL A R. Collateral Sensitivity Interactions between Antibiotics Depend on Local Abiotic Conditions [J]. mSystems, 2021, 6(6): e0105521.
[17]LIN D L, TRAN T, ALAM J Y, et al. Inhibition of aminoglycoside 6'-N-acetyltransferase type Ib by zinc: reversal of amikacin resistance in Acinetobacter baumannii and Escherichia coli by a zinc ionophore [J]. Antimicrobial agents and chemotherapy, 2014, 58(7): 4238-41.
[18]ARDELL S M, KRYAZHIMSKIY S. The population genetics of collateral resistance and sensitivity [J]. eLife, 2021, 10.
[19]KRUEGER A S, MUNCK C, DANTAS G, et al. Simulating Serial-Target Antibacterial Drug Synergies Using Flux Balance Analysis [J]. PloS one, 2016, 11(1): e0147651.
[20]SZENDRO I G, SCHENK M F, FRANKE J, et al. Quantitative analyses of empirical fitness landscapes [J]. Journal of Statistical Mechanics: Theory and Experiment, 2013, 2013(01): P01005.
[21]ZWEP L B, HAAKMAN Y, DUISTERS K L W, et al. Identification of antibiotic collateral sensitivity and resistance interactions in population surveillance data [J]. JAC-antimicrobial resistance, 2021, 3(4): dlab175.
[22]HERNANDO-AMADO S, LABORDA P, VALVERDE J R, et al. Mutational background influences P. aeruginosa ciprofloxacin resistance evolution but preserves collateral sensitivity robustness [J]. Proc Natl Acad Sci U S A, 2022, 119(15): e2109370119.
[23]UDEKWU K I, WEISS H. Pharmacodynamic considerations of collateral sensitivity in design of antibiotic treatment regimen [J]. Drug design, development and therapy, 2018, 12: 2249-57.
版权与开放获取声明
作为一本开放获取的学术期刊，所有文章均遵循 Creative Commons Attribution 4.0 International License (CC BY 4.0) 协议发布，允许用户在署名原作者的前提下自由共享与再利用内容。所有文章均可免费供读者和机构阅读、下载、引用与传播，EWA Publishing 不会通过期刊的出版发行向读者或机构收取任何费用。